iMDx develops molecular diagnostic tests for transplanted organ rejection and sells them to hospitals, transplant centers and labs. It last closed at $1.78 on Nov 17, down 4.30% on the day. IMDX last reported earnings on Mon, Nov 16, 2026.
Only 1 firm rated IMDX in the past 90 days, not enough for a consensus
Average 12-month target
$8.00
▲ 349.4% upside
Based on 1 analyst who set a price target on IMDX in the past 90 days. The average target is $8.00, with a high of $8.00 and a low of $8.00, compared with the last close of $1.78.
Low $8.00Avg $8.00High $8.00
Blue marker: last close $1.78
Highest target$8.00
Average target$8.00
Lowest target$8.00
Latest rating changes
LUCID CAPITAL MARKETSInitiated
Aug 24Buy$8
NeedhamReiterated
Aug 18Buy$9
Date
Firm
Action
Rating
Price target
Aug 24
LUCID CAPITAL MARKETS
Initiated
Buy
$8
Aug 18
Needham
Reiterated
Buy
$9
Loading…
Technical Analysis
IMDX · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 48% below its 20 day and 80% below its 50 day average. It is 152% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 21), oversold. The nearest support is the Pivot at $1.74, and the nearest resistance the Pivot R1 at $1.84.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 14.6%/day
Key levels
$7.5652 week high+324.7%
$4.48200 day average+151.7%
$3.92100 day average+120.2%
$3.25Swing high (Oct 27)+82.6%
$3.2050 day average+79.8%
$2.6420 day average+48.3%
$1.84Pivot R1+3.4%
$1.78Last close
$1.74Pivot−2.2%
$1.68Pivot S1−5.6%
$1.6452 week low−7.9%
Indicators
RSI (14)
20.69
Oversold below 30
Oversold
MACD
-0.35
Below its signal line
Bearish
Stochastic
5.0
Near the bottom of its range
Oversold
ADX (14)
40.1
Strong downtrend
Williams %R
-91.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-185.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−35.0%
Change over 10 sessions
Bearish
ATR (14)
$0.26
Typical daily range, 14.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 42.3%/day
Key levels
$7.5652 week high+324.7%
$4.48200 day average+151.7%
$3.92100 day average+120.2%
$3.25Swing high (Oct 27)+82.6%
$3.2050 day average+79.8%
$2.6420 day average+48.3%
$1.84Pivot R1+3.4%
$1.78Last close
$1.74Pivot−2.2%
$1.68Pivot S1−5.6%
$1.6452 week low−7.9%
Indicators
RSI (14)
24.49
Oversold below 30
Oversold
MACD
-0.72
Below its signal line
Bearish
Stochastic
3.9
Near the bottom of its range
Oversold
ADX (14)
29.2
Trending down
Williams %R
-95.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-169.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−57.6%
Change over 10 sessions
Bearish
ATR (14)
$0.75
Typical daily range, 42.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IMDX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IMDX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow IMDX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How IMDX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IMDX is in one of them and how their past IMDX trades turned out.
iMDx is a diagnostics company based in Nashville, Tennessee. Its main focus is molecular tests that help monitor whether a transplanted organ is being rejected, sold under the GraftAssure name. The test kits are meant for hospitals, transplant centers and labs to run in their own facilities, and research kits are offered to research laboratories. The company also runs a clinical lab in Franklin, Tennessee, and provides assay development and testing services to life sciences and biotechnology companies.